Repurposing Allergy Meds to Treat Hep C

Share

Follow Us

New research targets an old, over-the-counter hay fever drug in hopes that everyone in need will be able to afford a safe and effective Hepatitis C treatment.

New HCV Drugs

Because of the great medical demand for better options, the standard of care for Hepatitis C has been a major focus of the pharmaceutical industry, and it has steadily been upgraded. Over the past several years, treatment protocols for this virus have boosted the Hepatitis C treatment success rate to the 90th percentile. The medications leading the way are now:

Besides boasting a much higher ‘cure’ rate, these amazing drugs do so with fewer side effects and in about half the length of time than pegylated interferon and ribavirin.

However, only those with the most money, the best insurance plans, or those with the most advanced form of liver disease seem to be able to afford or qualify for these treatments. This is not a surprise, considering one dose can run somewhere in the vicinity of $1,000. Treating Hepatitis C in this manner can quickly put health insurance companies out of business, with a 12-week course of Sovaldi costing approximately $84,000, and a 12-week course of Harvoni carrying an approximate price tag of $94,500.

You'll also receive the latest news and information to support liver health.
Rest assured, we will not rent your email to anyone.

People Who Read This Also Viewed These Products

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.